Exelixis (EXEL) director Beckerle sells 9,812 shares via Rule 10b5-1 plan

Rhea-AI Filing Summary

EXELIXIS, INC. director Mary C. Beckerle reported selling 9,812 shares of Common Stock on August 10, 2026 in an open-market transaction at a weighted average price of $53.66 per share, with individual trade prices ranging from $53.16 to $54.02.

After this sale, Beckerle’s reported holdings consist of 16,079 shares, all to be issued upon vesting of restricted stock units, each RSU being the economic equivalent of one share of Common Stock. The sale was executed under a Rule 10b5-1 trading plan adopted on May 8, 2026.

Insider Trade Summary 10b5-1

Net Seller: 9,812 shares

Net Sell 1 txn

Insider Beckerle Mary C

Role Director

Sold 9,812 shs ($527K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2, F3	9,812	$53.66	$527K

Holdings After Transaction: Common Stock — 16,079 shares (Direct)

Footnotes (3)

1. F1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026.
2. F2. Represents the weighted average sales price. The shares of Exelixis, Inc. common stock ("Common Stock") were sold in multiple transactions at prices ranging from $53.16 to $54.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
3. F3. Includes 16,079 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.

Key Figures

Shares sold: 9,812 shares Weighted average sale price: $53.66 per share Sale price range: $53.16 to $54.02 per share +3 more

6 metrics

Shares sold 9,812 shares Common Stock sold by Mary C. Beckerle on August 10, 2026

Weighted average sale price $53.66 per share Weighted average price for 9,812 shares sold

Sale price range $53.16 to $54.02 per share Range of prices for multiple sale transactions

Holdings after transaction 16,079 shares Shares to be issued upon vesting of RSUs after the sale

Net shares sold 9,812 shares Net sell direction per transaction summary

Rule 10b5-1 plan adoption date May 8, 2026 Adoption date of trading plan covering these sales

Key Terms

Rule 10b5-1 trading plan, weighted average sales price, restricted stock units, economic equivalent

4 terms

Rule 10b5-1 trading plan regulatory

"The sales were effected pursuant to a Rule 10b5-1 trading plan adopted"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sales price financial

"Represents the weighted average sales price. The shares were sold"

restricted stock units financial

"Includes 16,079 shares of Common Stock that will be issued upon vesting of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

economic equivalent financial

"Each RSU is the economic equivalent of one share of Common Stock"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/12/2026 - 07:34 PM Accepted by SEC EDGAR 08/12/2026 - 07:34 PM Learn about SEC filing dates

FAQ

What did EXEL (Exelixis, Inc.) director Mary C. Beckerle report in this Form 4?

Mary C. Beckerle reported selling 9,812 shares of Exelixis, Inc. Common Stock on August 10, 2026. The transaction was conducted in the open market under a Rule 10b5-1 trading plan and is reflected as a direct ownership sale.

At what price did Mary C. Beckerle sell EXEL shares on August 10, 2026?

The reported sale used a weighted average price of $53.66 per share for 9,812 shares. Individual trades occurred in multiple transactions at prices ranging from $53.16 to $54.02, as disclosed in the Form 4 footnotes.

How many EXEL shares does Mary C. Beckerle report holding after this Form 4 transaction?

Following the sale, Beckerle reports 16,079 shares of Exelixis, Inc. Common Stock. According to the filing, these shares will be issued upon vesting of restricted stock units (RSUs), each RSU representing one share economically.

Was Mary C. Beckerle’s EXEL stock sale made under a Rule 10b5-1 trading plan?

Yes. The Form 4 states the sales were effected under a Rule 10b5-1 trading plan. The trading plan was adopted on May 8, 2026, and the Rule 10b5-1 checkbox on the form is affirmed for this transaction.

What type of security is involved in Mary C. Beckerle’s EXEL Form 4 filing?

The transaction involves Common Stock of Exelixis, Inc. In addition, the post-transaction position consists of restricted stock units (RSUs), each RSU being the economic equivalent of one share of Common Stock upon vesting.

How large is Mary C. Beckerle’s EXEL stock sale reported in this Form 4?

The filing reports a sale of 9,812 shares of Exelixis, Inc. Common Stock. The Form 4’s transaction summary classifies this as a net sell of 9,812 shares, with no corresponding purchases or derivative exercises reported.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Beckerle Mary C

(Last) (First) (Middle)

C/O EXELIXIS, INC.

1851 HARBOR BAY PARKWAY

(Street)

ALAMEDA CALIFORNIA 94502

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EXELIXIS, INC. [ EXEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/10/2026		S(1)		9,812	D	$53.66(2)	16,079(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026.

2. Represents the weighted average sales price. The shares of Exelixis, Inc. common stock ("Common Stock") were sold in multiple transactions at prices ranging from $53.16 to $54.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.

3. Includes 16,079 shares of Common Stock that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.

Remarks:

	/s/ Nina Ayer, Attorney in Fact	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)